Trichomoniasis in pregnant human immunodeficiency virus-infected and human immunodeficiency virus-uninfected congolese women: prevalence, risk factors, and association with low birth weight
- PMID: 10486480
- DOI: 10.1016/s0002-9378(99)70509-0
Trichomoniasis in pregnant human immunodeficiency virus-infected and human immunodeficiency virus-uninfected congolese women: prevalence, risk factors, and association with low birth weight
Abstract
Objective: We sought to assess the prevalence of and risk factors for vaginal trichomoniasis in human immunodeficiency virus-infected and human immunodeficiency virus-uninfected pregnant Congolese women and its relationship to pregnancy outcomes.
Study design: We performed a nested case-control study of 215 infected and 206 uninfected mothers who responded to questionnaires, underwent sexually transmitted disease testing (including culture for trichomoniasis shortly after delivery), and underwent assessment of infant outcomes. Maternal variables and birth outcomes were assessed according to presence or absence of trichomoniasis and human immunodeficiency virus.
Results: Trichomoniasis was present in 18.6% of human immunodeficiency virus-positive and 10.2% of human immunodeficiency virus-negative women, respectively (odds ratio, 2.0; 95% confidence interval, 1.1-3.6), and was significantly associated with low birth weight (odds ratio, 2.4; 95% confidence interval, 1.2-4.5). In multivariate analyses trichomoniasis remained associated with low birth weight, and adjustments were made for other risk factors associated with low birth weight.
Conclusion: These findings suggest an association between trichomoniasis and low birth weight independent of human immunodeficiency virus infection and other risk factors. Further studies are needed to assess the impact of antenatal screening and treatment for trichomoniasis on pregnancy outcomes.
Similar articles
-
The effect of human immunodeficiency virus infection on birthweight, and infant and child mortality in urban Malawi.Int J Epidemiol. 1995 Oct;24(5):1022-9. doi: 10.1093/ije/24.5.1022. Int J Epidemiol. 1995. PMID: 8557435
-
Impact of maternal human immunodeficiency virus infection on pregnancy and birth outcomes in Pune, India.AIDS Care. 2011 Dec;23(12):1562-9. doi: 10.1080/09540121.2011.579948. Epub 2011 Jun 28. AIDS Care. 2011. PMID: 21711178
-
Perinatal human immunodeficiency virus-1 transmission and intrauterine growth: a cohort study in Butare, Rwanda.Pediatrics. 1998 Aug;102(2):e24. doi: 10.1542/peds.102.2.e24. Pediatrics. 1998. PMID: 9685470
-
Current issues and considerations regarding trichomoniasis and human immunodeficiency virus in African-Americans.Clin Microbiol Rev. 2009 Jan;22(1):37-45, Table of Contents. doi: 10.1128/CMR.00002-08. Clin Microbiol Rev. 2009. PMID: 19136432 Free PMC article. Review.
-
A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections.Clin Infect Dis. 2015 Dec 15;61 Suppl 8(Suppl 8):S837-48. doi: 10.1093/cid/civ738. Clin Infect Dis. 2015. PMID: 26602621 Free PMC article. Review.
Cited by
-
Adverse perinatal outcomes attributable to HIV in sub-Saharan Africa from 1990 to 2020: Systematic review and meta-analyses.Commun Med (Lond). 2023 Jul 22;3(1):103. doi: 10.1038/s43856-023-00331-8. Commun Med (Lond). 2023. PMID: 37481594 Free PMC article.
-
Urogenital Schistosomiasis and Sexually Transmitted Coinfections among Pregnant Women in a Schistosome-Endemic Region of the Democratic Republic of Congo.Am J Trop Med Hyg. 2019 Oct;101(4):828-836. doi: 10.4269/ajtmh.19-0024. Am J Trop Med Hyg. 2019. PMID: 31392943 Free PMC article.
-
The prevalence and risk factors for Trichomonas vaginalis infection amongst human immunodeficiency virus-infected pregnant women attending the antenatal clinics of a university teaching hospital in Lagos, South-Western, Nigeria.Niger Postgrad Med J. 2018 Jan-Mar;25(1):21-26. doi: 10.4103/npmj.npmj_7_18. Niger Postgrad Med J. 2018. PMID: 29676341 Free PMC article.
-
Prevalence and Detection of Trichomonas vaginalis in HIV-Infected Pregnant Women.Sex Transm Dis. 2018 May;45(5):332-336. doi: 10.1097/OLQ.0000000000000756. Sex Transm Dis. 2018. PMID: 29465686 Free PMC article.
-
Sulfadoxine-Pyrimethamine Exhibits Dose-Response Protection Against Adverse Birth Outcomes Related to Malaria and Sexually Transmitted and Reproductive Tract Infections.Clin Infect Dis. 2017 Apr 15;64(8):1043-1051. doi: 10.1093/cid/cix026. Clin Infect Dis. 2017. PMID: 28329383 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical